Last update 29 Mar 2025

ACC-015

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1'-cyano-cytarabine derivate(Jiangsu Aidea Pharmaceutical/Kainos Medicine), Ara-C derivate(Jiangsu Aidea Pharmaceutical/Kainos Medicine), ACC 015
+ [2]
Target
DNA polymerase
Action
inhibitors
Mechanism
DNA polymerase inhibitors(DNA polymerase inhibitors)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Acute Myeloid Leukemia
Inactive Indication-
Originator Organization
Kainos Medicine, Inc.Kainos Medicine, Inc.
Active Organization
Kainos Medicine, Inc.Kainos Medicine, Inc.
Inactive Organization
Jiangsu Aidea Pharmaceutical Co., Ltd.Jiangsu Aidea Pharmaceutical Co., Ltd.
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with ACC-015
EUCTR2010-021944-17-DE
/ Not yet recruitingPhase 2IIT
Randomized, Multi-centre, Phase II Trial to compare the Event-Free Survival of Clofarabine / Ara-C (ClAraC) or of FLAMSA Treatment in Patients with High Risk AML or Advanced MDS scheduled for Allogeneic Stem Cell Transplantation - ClAraC-SCT
100 Clinical Results associated with ACC-015
Login to view more data
100 Translational Medicine associated with ACC-015
Login to view more data
100 Patents (Medical) associated with ACC-015
Login to view more data
1
Literatures (Medical) associated with ACC-015
01 Apr 1969Cancer research
Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.
100 Deals associated with ACC-015
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPreclinical
China
Jiangsu Aidea Pharmaceutical Co., Ltd.Jiangsu Aidea Pharmaceutical Co., Ltd.
-
Acute Myeloid LeukemiaPreclinical
South Korea
Kainos Medicine, Inc.Kainos Medicine, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free